Drug and Medication Analysis & Statistics, January 2013 (p50)

Talk to Louis

+1 718 618 4302

Search inside this page

Publishers

All regions

You might be interested in: drug, vaccine, smoking cessation, more »

1471-1510 of about 5 000 reports

Purchase Reports From Reputable Market Research Publishers

Analgesics Market Overview in Latvia

Analgesics Market Overview in Latvia

  • $ 898
  • Industry report
  • March 2014
  • by Euromonitor International

An increasing amount of consumers chose ibuprofen and combination products over acetaminophen in 2010. As a result, acetaminophen value reduced by less than 1% in 2010. However, it was still popular due ...

  • Industries : Drug and Medication
  • Countries : Latvia
Analgesics Market Analysis in Belarus

Analgesics Market Analysis in Belarus

  • $ 898
  • Industry report
  • March 2014
  • by Euromonitor International

Combination products, mainly with vitamin C added, were widely used as analgesics and cold and flu treatments, with demand being boosted by the self-medication trend. Euromonitor International's report ...

  • Industries : Drug and Medication
  • Countries : Belarus
Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Lithuania

Cough, Cold and Allergy (hay Fever) Remedies Market Overview in Lithuania

  • $ 898
  • Industry report
  • March 2014
  • by Euromonitor International

Cough, cold and allergy (hay fever) remedies declined by -4% in 2010 which was slower than the 2009 rate of -10%. The 2009 decline occurred despite the panic concerning swine flu, when less educated consumers ...

  • Industries : Drug and Medication
  • Countries : Lithuania
Ophthalmic Drugs; Data, Analysis and Forecasts to 2024

Ophthalmic Drugs; Data, Analysis and Forecasts to 2024

  • $ 2 249
  • Industry report
  • March 2014
  • by GMR Data Ltd

Ophthalmic Drugs; Data, Analysis and Forecasts to 2024 Which ophthalmic drugs lead the market in 2013? Will the same drugs be as successful in 2018? How will this landscape change across the next 10 years? ...

  • Industries : Drug and Medication
  • Countries : World, United States
The Medicines Company Partnering 2009-2014

The Medicines Company Partnering 2009-2014

  • $ 995
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Partnering Agreements ...

  • Industries : Drug and Medication
Vaccine Deals and Alliances of 2013

Vaccine Deals and Alliances of 2013

  • $ 1 495
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Vaccine Deals and ...

  • Industries : Drug and Medication
Contraception Partnering 2009-2014

Contraception Partnering 2009-2014

  • $ 995
  • Industry report
  • March 2014
  • by Currentpartnering

The report will be delivered in PDF format within 3 working days of receipt of order. If print or CD-Rom version purchased, the report will be sent by courier using express service. The Contraception Partnering ...

  • Industries : Drug and Medication
Autoinjectors to 2020 : Devices, Markets, Players, Strategies and Forecasts

Autoinjectors to 2020 : Devices, Markets, Players, Strategies and Forecasts

  • $ 2 850
  • Industry report
  • March 2014
  • by Greystone Research Associates

Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the ...

  • Industries : Drug and Medication
Analysis of Gilead Sciences

Analysis of Gilead Sciences

  • $ 300
  • Company report
  • March 2014
  • by Aruvian's R'search

Based in the United States, Gilead Sciences is a global leader in the marketing and development of anti-infective drugs. The company has approved products for the treatment of Hepatitis B & C, HIV/AIDS, ...

  • Industries : Drug and Medication
  • Countries : United States
2014 Deep Research Report on Global and China 6-Aminopenicillin Acid (6-APA) Industry

2014 Deep Research Report on Global and China 6-Aminopenicillin Acid (6-APA) Industry

  • $ 2 200
  • Industry report
  • March 2014
  • by QY Research Group

Summary "2014 Deep Research Report on Global and China 6-Aminopenicillin Acid (6-APA) Industry" was professional and depth research report on Global and China 6-Aminopenicillin Acid (6-APA) Industry. The ...

  • Industries : Drug and Medication
  • Countries : China, World
Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

  • $ 2 500
  • Industry report
  • March 2014
  • by Kelly Scientific Publications

“Pharmaceutical Industry China - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” ...

  • Industries : Drug and Medication
  • Countries : China
MarketVIEW: Rabies vaccines

MarketVIEW: Rabies vaccines

  • $ 4 495
  • Industry report
  • March 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Rabies is a viral zoonosis caused by all members of the Lyssavirus genus and mostly spread by canine vectors. The disease, if untreated is 100% fatal, although almost 100% preventable through timely postexposure ...

  • Industries : Drug and Medication
  • Countries : China, World, Asia, India, Africa, South Africa, Brazil, Canada, Vietnam, Thailand, Philippines, United States, Europe, Sri Lanka, Indonesia, Bangladesh, Russian Federation, Nepal, Myanmar, Cambodia
World Drug and Medication: Tuberculosis – Pipeline Review, H1 2012

World Drug and Medication: Tuberculosis – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Tuberculosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Drug and Medication
World Drug and Medication: Substance (Drug) Abuse – Pipeline Review, H1 2012

World Drug and Medication: Substance (Drug) Abuse – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Substance (Drug) Abuse, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key ...

  • Industries : Drug and Medication
  • Countries : World
Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2014', provides an overview of the Varicella ...

  • Industries : Drug and Medication
  • Countries : World, United States
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2014', provides an overview of the Opioid-Induced ...

  • Industries : Drug and Medication
  • Countries : World, United States
World Drug and Medication: Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H1 2012

World Drug and Medication: Respiratory Syncytial Virus (RSV) Infections – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Respiratory Syncytial Virus (RSV) Infections, complete with latest updates, and special features on late-stage and discontinued projects. ...

  • Industries : Drug and Medication
Drug and Medication in Japan: HIV-1 Infection – Pipeline Review, H1 2012

Drug and Medication in Japan: HIV-1 Infection – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for HIV-1 Infection, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Drug and Medication
World Drug and Medication: Vancomycin-Resistant Enterococcus Faecium Infections – Pipeline Review, H1 2012

World Drug and Medication: Vancomycin-Resistant Enterococcus Faecium Infections – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Vancomycin-Resistant Enterococcus Faecium Infections, complete with latest updates, and special features on late-stage and discontinued ...

  • Industries : Drug and Medication
  • Countries : World
World Drug and Medication: Cytomegalovirus (HHV-5) Infections – Pipeline Review, H1 2012

World Drug and Medication: Cytomegalovirus (HHV-5) Infections – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides information on the therapeutic development for Cytomegalovirus (HHV-5) Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also ...

  • Industries : Drug and Medication
  • Countries : World
Inflammatory Pain - Pipeline Review, H1 2014

Inflammatory Pain - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Inflammatory Pain - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammatory Pain - Pipeline Review, H1 2014', provides an overview of the Inflammatory Pain's therapeutic pipeline. This ...

  • Industries : Drug and Medication
  • Countries : World
Therapy in Canada: Acute Pain – Pipeline Review, H1 2012

Therapy in Canada: Acute Pain – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Acute Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Drug and Medication
  • Countries : World
Malignant Pleural Mesothelioma - Pipeline Review, H1 2014

Malignant Pleural Mesothelioma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Malignant Pleural Mesothelioma - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2014', provides an overview of the Malignant Pleural Mesothelioma's ...

  • Industries : Drug and Medication
  • Countries : World
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Metastatic Hormone Refractory (Castration Resistant, ...

  • Industries : Drug and Medication
LiPlasome Pharma ApS - Product Pipeline Review - 2014

LiPlasome Pharma ApS - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • February 2014
  • by Global Markets Direct

LiPlasome Pharma ApS - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘LiPlasome Pharma ApS - Product Pipeline Review - 2014', provides an overview of the LiPlasome Pharma ApS's pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : World
Age Related Macular Degeneration - Pipeline Review, H1 2014

Age Related Macular Degeneration - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Age Related Macular Degeneration - Pipeline Review, H1 2014', provides an overview of the Age Related Macula ...

  • Industries : Drug and Medication
  • Countries : United States
Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases

Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases

  • $ 3 900
  • Industry report
  • February 2014
  • by CBR Pharma Insights

More than 50% of prescriptions is written for people aged 65 years and older. Many older people suffer from comorbid conditions and one in three takes at least five drugs or more on a daily basis. This ...

  • Industries : Drug and Medication
Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

Vaccine Development Strategies - Refocusing Efforts to Address New Challenges

  • $ 3 900
  • Industry report
  • February 2014
  • by CBR Pharma Insights

Vaccines are one of the most important healthcare advances and have saved millions of lives through immunizing against some of the most deadly diseases. With protection against a number of key viral and ...

  • Industries : Drug and Medication
PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022

  • $ 9 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - Global Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of ...

  • Industries : Drug and Medication
  • Countries : World
PharmaPoint: Ulcerative Colitis - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Ulcerative Colitis - US Drug Forecast and Market Analysis to 2022

  • $ 4 995
  • Industry report
  • February 2014
  • by Global Data

PharmaPoint: Ulcerative Colitis - US Drug Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson ...

  • Industries : Drug and Medication
  • Countries : United States
About 14 000 reports

Download Unlimited Documents from Trusted Public Sources

US - Country Risk

  • Risk of Endometrial Cancer in Relation to Medical Conditions and...
  • July 2014
    10 pages
  • Endometrial Can...  

  • United States  

View report >

85 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.